प्रॉक्टर आणि गॅम्बल हायजीन आणि हेल्थकेअर शेअर किंमत

<h3><span style="font-size:16px;"><strong>वैयक्तिक उत्पादने कंपनी प्रॉक्टर आणि गॅम्बल हायजीन आणि हेल्थकेअरने Q1FY27 परिणामांची घोषणा केली</strong></span></h3><p _ngcontent-ng-c2348603712=""><strong _ngcontent-ng-c2348603712="">फायनान्शियल हायलाईट्स:</strong></p><ul><li _ngcontent-ng-c2348603712="">Total Income for Q1FY27 stood at Rs 90,089 lakh, representing a YoY decline of 4.64% from Rs 94,472 lakh in Q1FY26 and a QoQ decrease of 5.55% from Rs 95,379 lakh in Q4FY26.</li><li _ngcontent-ng-c2348603712="">Revenue from Operations in Q1FY27 was Rs 89,146 lakh, reflecting a YoY decrease of 4.86% compared to Rs 93,703 lakh in Q1FY26 and a QoQ decline of 5.30% from Rs 94,132 lakh in Q4FY26.</li><li _ngcontent-ng-c2348603712="">Profit Before Tax (PBT) for Q1FY27 was reported at Rs 16,963 lakh, down 35.92% YoY from Rs 26,470 lakh in Q1FY26 and down 22.23% QoQ from Rs 21,811 lakh in Q4FY26.</li><li _ngcontent-ng-c2348603712="">Net Profit for the period reached Rs 12,627 lakh in Q1FY27, showing a YoY decline of 34.25% from Rs 19,206 lakh in Q1FY26 and a QoQ decrease of 17.54% from Rs 15,313 lakh in Q4FY26.</li><li _ngcontent-ng-c2348603712="">Total Comprehensive Income for Q1FY27 was Rs 12,734 lakh, marking a 33.08% YoY decrease from Rs 19,029 lakh in Q1FY26 and a 17.21% QoQ decline from Rs 15,382 lakh in Q4FY26.</li><li _ngcontent-ng-c2348603712="">Earnings Per Share (EPS) (Basic & Diluted) for Q1FY27 stood at Rs 38.90, compared to Rs 59.17 in Q1FY26 and Rs 47.17 in Q4FY26.</li><li _ngcontent-ng-c2348603712="">Other Income for Q1FY27 was Rs 943 lakh, an increase from Rs 769 lakh in Q1FY26, but a decline from Rs 1,247 lakh in Q4FY26.</li></ul><p _ngcontent-ng-c2348603712=""><strong _ngcontent-ng-c2348603712="">बिझनेस हायलाईट्स:</strong></p><ul><li _ngcontent-ng-c2348603712=""><strong _ngcontent-ng-c2348603712="">Segment Performance:</strong> The Company has two primary operating segments: Health Care Products (comprising ointments, creams, cough drops, and tablets) and Hygiene Products (comprising feminine hygiene products and other skin care hygiene).</li><li _ngcontent-ng-c2348603712=""><strong _ngcontent-ng-c2348603712="">Single Reportable Segment:</strong> These individual operating segments have been aggregated into a single primary reportable segment—manufacturing, trading, and marketing of Health and Hygiene Products—in accordance with Ind AS 108.</li><li _ngcontent-ng-c2348603712=""><strong _ngcontent-ng-c2348603712="">Operational Structure:</strong> The Company confirmed that it does not have any subsidiary, associate, or joint venture as of June 30, 2026.</li></ul><p><strong>Kumar Venkatasubramanian, Managing Director, Procter & Gamble Hygiene and Health Care, said:</strong> “We continue to invest strategically behind our brands, innovation and market capabilities, even as the geopolitical environment remains challenging. Our confidence in the Integrated Growth Strategy - focused product portfolio of daily use categories where performance drives brand choice, superiority (of product performance, packaging, brand communication, retail execution and value), productivity, constructive disruption, and an agile and accountable organization; remains unwavering, and we believe the continued execution of this strategy will strengthen our business, unlock future growth opportunities and build an even stronger company for the future.”</p><p><a class="lb" href="/marathi/get-document/post/pdf/5752669/" target="_blank">रिझल्ट PDF</a></p>

• ट्रेंडलाईन
• 3 दिवस 1 तासांपूर्वी

Company has informed the exchange about the unaudited financial results for the quarter ended June 30, 2026

• बीएसई इंडिया
• 3 दिवस 1 तासांपूर्वी

Company has informed the exchange about the press release for the quarter ended on June 30, 2026

• बीएसई इंडिया
• 3 दिवस 1 तासांपूर्वी